Genomic Tools in Clinical Epidemiology

Alfredo García-Venzor, Esteban Cruz-Arenas, Victor Takeshi Landero-Yoshioka, Edna Ayerim Mandujano-Tinoco

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review


The advent of high-throughput technologies, including next-generation sequencing (NGSs), is currently revolutionizing our understanding of several aspects in biological and medical sciences. Particularly, genomic, transcriptomic, epigenomic, and interactomic studies are having a profound impact on the progress of clinical epidemiology. This science is improving public health practices by linking the knowledge from the etiology, distribution, and risk factors during the appearance and progress of infectious and chronic diseases. In this sense, genomic tools have been incorporated in epidemiological studies for the identification of rare genetic variants, genetic and environmental risk factors, and accurate biomarkers for the diagnosis and treatment of several diseases. In this chapter, we aim to highlight the influence that genomics is having on different epidemiological traits by illustrating some examples about the control of the COVID-19 pandemic and the diagnoses, screening, and treatment of chronic diseases such as the infection caused by Helicobacter pylori, cancer, and rheumatoid arthritis.

Original languageEnglish
Title of host publicationPrinciples of Genetics and Molecular Epidemiology
PublisherSpringer International Publishing
Number of pages19
ISBN (Electronic)9783030896010
ISBN (Print)9783030896003
StatePublished - 1 Jan 2022


  • Chip-seq
  • Methyl-seq
  • NGS technologies
  • RNA-seq
  • scRNA-seq
  • WES
  • WGS

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology (all)
  • Medicine (all)


Dive into the research topics of 'Genomic Tools in Clinical Epidemiology'. Together they form a unique fingerprint.

Cite this